Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New spinal implant for kids with scoliosis under Long-Term safety review

NCT ID NCT07403084

Disease control Sponsor: EUROS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is tracking 140 children aged 5 to 17 with progressive scoliosis who receive the NEMOST V2 growing domino implant. The implant is designed to straighten the spine as the child grows. Researchers will monitor complications and how well the device works over 5 years after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
NEMOST V2 growing domino (spinal implant)
What this could lead to
If successful, this could confirm that the NEMOST implant is a safe and effective way to correct progressive scoliosis in growing children, reducing the need for repeated surgeries.
What could go wrong
This is an observational post-market study, not a randomized trial, so results may not prove the device is better than other treatments. Complications like infection or implant failure are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 140 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Dec 2033

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Idiopathic, congenital, neuromuscular, or syndromic scoliosis : Progressive spinal deformity not managed by orthopedic treatment, and requiring primary surgical intervention. * The patient, as well as their parents or legal guardians, are informed of the participation in the study. * Patients aged from 5 to 17 yeas old, excepted the one who still have a potential for growth Exclusion Criteria: * signs of local inflammation; * acute or chronic, local or systemic infections ; * non-reducible scoliosis ; * pathological obesity ; * allergy or intolerance to implanted materials; * insufficiency or absence of tissue coverage. The NEMOST implant should not be used in a spine that has already been instrumented or fused.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Consent forms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

idiopathic scoliosis scoliosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Consent forms Scoliosis idiopathic Scoliosis neuromuscular

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Pellegrin

    RECRUITING

    Bordeaux, France

  • Hopital Armand Trousseau

    NOT_YET_RECRUITING

    Paris, France

  • Hopital Lenval Nice

    RECRUITING

    Nice, Provence-Alpes-Côte d'Azur Region, 06000, France

  • Hopital Necker

    NOT_YET_RECRUITING

    Paris, France

  • Hospices Civils de Lyon

    NOT_YET_RECRUITING

    Lyon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.